1. Home
  2. XOMA vs RAC Comparison

XOMA vs RAC Comparison

Compare XOMA & RAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • RAC
  • Stock Information
  • Founded
  • XOMA 1981
  • RAC 2024
  • Country
  • XOMA United States
  • RAC United States
  • Employees
  • XOMA N/A
  • RAC N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • RAC
  • Sector
  • XOMA Health Care
  • RAC
  • Exchange
  • XOMA Nasdaq
  • RAC Nasdaq
  • Market Cap
  • XOMA 330.2M
  • RAC 300.6M
  • IPO Year
  • XOMA N/A
  • RAC 2025
  • Fundamental
  • Price
  • XOMA $25.83
  • RAC $10.27
  • Analyst Decision
  • XOMA Strong Buy
  • RAC
  • Analyst Count
  • XOMA 2
  • RAC 0
  • Target Price
  • XOMA $69.50
  • RAC N/A
  • AVG Volume (30 Days)
  • XOMA 59.0K
  • RAC 362.0
  • Earning Date
  • XOMA 08-12-2025
  • RAC 01-01-0001
  • Dividend Yield
  • XOMA N/A
  • RAC N/A
  • EPS Growth
  • XOMA N/A
  • RAC N/A
  • EPS
  • XOMA N/A
  • RAC N/A
  • Revenue
  • XOMA $42,909,000.00
  • RAC N/A
  • Revenue This Year
  • XOMA $70.91
  • RAC N/A
  • Revenue Next Year
  • XOMA $14.00
  • RAC N/A
  • P/E Ratio
  • XOMA N/A
  • RAC N/A
  • Revenue Growth
  • XOMA 638.41
  • RAC N/A
  • 52 Week Low
  • XOMA $18.35
  • RAC $10.00
  • 52 Week High
  • XOMA $35.00
  • RAC $10.70
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 48.34
  • RAC N/A
  • Support Level
  • XOMA $25.42
  • RAC N/A
  • Resistance Level
  • XOMA $26.63
  • RAC N/A
  • Average True Range (ATR)
  • XOMA 0.89
  • RAC 0.00
  • MACD
  • XOMA -0.19
  • RAC 0.00
  • Stochastic Oscillator
  • XOMA 12.50
  • RAC 0.00

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About RAC Rithm Acquisition Corp. Class A Ordinary Shares

Rithm Acquisition Corp is a blank check company.

Share on Social Networks: